Blue Sky’s biochemical-based and cell-based compound screening services are performed in 96-well or 384-well plates using both radiometric and fluorescent assays. Assay development and screen is supported for most target classes such as GPCRs, kinases, and proteases. Clients have the option of providing compounds for screening or using Blue Sky Bioservices’ proprietary focused compound library. We offer a complete package primary and secondary screening with hit identification, IC50/EC50 determination, and SAR.
Sample TrkA Primary Screening Data – HTRF Readout:
Interest in Blue Sky's Compound Screening Services? Please contact us for a free quote and additional information.